3-Phenyl-5-[(thiophen-2-yl)methylidene]-2-[(4H-1,2,4-triazol-4-yl)imino]-1,3-thiazolidin-4-one

Catalog No. :
ACEIDT594
CAS No. :
478077-87-1
Molecular Formula :
C16H11N5OS2
Molecular Weight :
353.43

IUPAC Name:(2Z,5E)-2-((4H-1,2,4-triazol-4-yl)imino)-3-phenyl-5-(thiophen-2-ylmethylene)thiazolidin-4-one

3-Phenyl-5-[(thiophen-2-yl)methylidene]-2-[(4H-1,2,4-triazol-4-yl)imino]-1,3-thiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$563.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Phenyl-5-[(thiophen-2-yl)methylidene]-2-[(4H-1,2,4-triazol-4-yl)imino]-1,3-thiazolidin-4-one
IUPAC Name(2Z,5E)-2-((4H-1,2,4-triazol-4-yl)imino)-3-phenyl-5-(thiophen-2-ylmethylene)thiazolidin-4-one
MDL No.MFCD02570967
Molecular FormulaC16H11N5OS2
Molecular Weight353.43
SMILESO=C1/C(=C\C2=CC=CS2)S/C(=N\N2C=NN=C2)N1C1=CC=CC=C1
InChI KeyBONRPASABPKPIG-DEKNBCERSA-N
Synonym3-PHENYL-5-[(Z)-2-THIENYLMETHYLIDENE]-2-(4H-1,2,4-TRIAZOL-4-YLIMINO)-1,3-THIAZOLAN-4-ONE;3-phenyl-5-[(thiophen-2-yl)methylidene]-2-[(4H-1,2,4-triazol-4-yl)imino]-1,3-thiazolidin-4-one;4-Thiazolidinone, 3-phenyl-5-(2-thienylmethylene)-2-(4H-1,2,4-triazol-4-ylimino)-
CAS No.478077-87-1

Synthetic Route by SureRoute

1. ACEIDT594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOYPU809 route compound structure diagram
    ACOYPU80998-03-3 In Stock
  4. Then
  5. ACEIDT594 route product structure diagram
    ACEIDT594478077-87-1
Inquiry

2. ACEIDT594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLUSY825 route compound structure diagram
    ACLUSY825584-13-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEIDT594 route product structure diagram
    ACEIDT594478077-87-1
Inquiry

Comments (0)